ALLISON BRILL: Open Payments
NPI 1013640275 · COLUMBIA, SC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$362 in 16 payments from 5 companies in 2025. Trend: 2023 $489 · 2024 $694 · 2025 $362
Food & beverage: $362
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 9 | $238 |
| AstraZeneca Pharmaceuticals LP | 3 | $57 |
| Novo Nordisk Inc | 2 | $37 |
| Amgen Inc. | 1 | $16 |
| PFIZER INC. | 1 | $15 |
Products named: QULIPTA, FARXIGA, AIRSUPRA, Rybelsus, UBRELVY, EVENITY, Ozempic, NURTEC ODT.
Industry payments across SC — which companies pay providers there.
